These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 4931099)

  • 1. Pharmacologic control of thromboembolic complications of cardiac-valve replacement.
    Sullivan JM; Harken DE; Gorlin R
    N Engl J Med; 1971 Jun; 284(25):1391-4. PubMed ID: 4931099
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacologic control of thromboembolic complications of cardiac-valve replacement. A preliminary report.
    Sullivan JM; Harken DE; Gorlin R
    N Engl J Med; 1968 Sep; 279(11):576-80. PubMed ID: 5667468
    [No Abstract]   [Full Text] [Related]  

  • 3. Use of Persantine in preventing thromboembolism following valve replacement.
    Arrants JE; Hairston P
    Am Surg; 1972 Aug; 38(8):432-5. PubMed ID: 5045046
    [No Abstract]   [Full Text] [Related]  

  • 4. Antiplatelet drugs and the incidence of thromboembolic complications of the St. Jude Medical aortic prosthesis in patients with rheumatic heart disease.
    Ribeiro PA; Al Zaibag M; Idris M; Al Kasab S; Davies G; Mashat E; Wareham E; Al Fagih M
    J Thorac Cardiovasc Surg; 1986 Jan; 91(1):92-8. PubMed ID: 3941564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prevention of systemic thromboembolic accidents in patients with artificial valve prostheses. Prospective study of an antivitamins K-dipyridamole combination].
    Starkman C; Estampes B; Vernant P; Acar J
    Arch Mal Coeur Vaiss; 1982 Jan; 75(1):85-8. PubMed ID: 6803719
    [No Abstract]   [Full Text] [Related]  

  • 6. Dipyridamole-aspirin as thromboembolic prophylaxis in patients with aortic valve prosthesis. Prospective study with the Model 2320 Starr-Edwards prosthesis.
    Brott WH; Zajtchuk R; Bowen TE; Davia J; Green DC
    J Thorac Cardiovasc Surg; 1981 Apr; 81(4):632-5. PubMed ID: 7206773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-dose oral anticoagulation and antiplatelet therapy with St. Jude Medical heart valve prosthesis.
    Yamak B; Iscan Z; Mavitas B; Ulus AT; Katircioglu SF; Tasdemir O; Bayazit K
    J Heart Valve Dis; 1999 Nov; 8(6):665-73. PubMed ID: 10616246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Late incidence and determinants of stroke after aortic and mitral valve replacement.
    Ruel M; Masters RG; Rubens FD; Bédard PJ; Pipe AL; Goldstein WG; Hendry PJ; Mesana TG
    Ann Thorac Surg; 2004 Jul; 78(1):77-83; discussion 83-4. PubMed ID: 15223407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral anticoagulation is not necessary for patients with bioprosthetic mitral valve replacement in atrial fibrillation.
    Nuñez L; Pinto AG; Larrea JL; Gil Aguado M; Connor FO
    Z Kardiol; 1986; 75 Suppl 2():321-5. PubMed ID: 3727711
    [No Abstract]   [Full Text] [Related]  

  • 10. Can early thromboembolic complications after valve replacement be avoided?
    Kure HH; Schüller H; Thulin L; Olin C
    Z Kardiol; 1986; 75 Suppl 2():302-4. PubMed ID: 3727707
    [No Abstract]   [Full Text] [Related]  

  • 11. Antiplatelet therapy in children with left-sided mechanical prostheses.
    LeBlanc JG; Sett SS; Vince DJ
    Eur J Cardiothorac Surg; 1993; 7(4):211-5. PubMed ID: 8481259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. German experience with low intensity anticoagulation (GELIA): protocol of a multi-center randomized, prospective study with the St. Jude Medical valve.
    Horstkotte D; Bergemann R; Althaus U; Babin-Ebell J; Chares M; Dahm M; Eigel P; Elert O; Emmrich K; Geiger AW
    J Heart Valve Dis; 1993 Jul; 2(4):411-9. PubMed ID: 8269143
    [No Abstract]   [Full Text] [Related]  

  • 13. [Replacement of the mitral and aortic valves with bioprostheses. Long-term results].
    Colombo T; Cicardi C; Peronace B; Pozzi M; Gordini V; Pellegrini A
    G Ital Cardiol; 1985 Oct; 15(10):974-82. PubMed ID: 4092917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The St. Jude Medical bileaflet valve prosthesis. A 5 year experience.
    Chaux A; Czer LS; Matloff JM; DeRobertis MA; Stewart ME; Bateman TM; Kass RM; Lee ME; Gray RJ
    J Thorac Cardiovasc Surg; 1984 Nov; 88(5 Pt 1):706-17. PubMed ID: 6492839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and hemodynamic results with the St. Jude Medical cardiac valve prosthesis. A three-year experience.
    Nicoloff DM; Emery RW; Arom KV; Northrup WF; Jorgensen CR; Wang Y; Lindsay WG
    J Thorac Cardiovasc Surg; 1981 Nov; 82(5):674-83. PubMed ID: 7300400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Late results of mitral and aortic valve replacement.
    Bonchek LI; Starr A
    Isr J Med Sci; 1975; 11(2-3):152-60. PubMed ID: 1112701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of long-term clinical follow-up after aortic or mitral valve replacement with Björk-Shiley tilting disc prostheses or tissue valves.
    Mudra H; Kraus F; Wellnhofer E; Hall D; Rudolph W
    Z Kardiol; 1986; 75 Suppl 2():277-81. PubMed ID: 3727700
    [No Abstract]   [Full Text] [Related]  

  • 18. [Long-term results after isolated aortic and mitral valve replacement with a prosthesis (author's transl)].
    Domanig E; Helmer F; Navrátil J; Wolner E
    Wien Klin Wochenschr; 1977 Jun; 89(12):409-12. PubMed ID: 878484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Five-years actuarial analysis after heart valve replacement with the St. Jude medical prosthesis.
    Fraedrich G; Höge R; Fiedler R; Hehrlein FW
    Z Kardiol; 1986; 75 Suppl 2():282-5. PubMed ID: 3727702
    [No Abstract]   [Full Text] [Related]  

  • 20. Long-term performance of the St. Jude Medical valve: low incidence of thromboembolism and hemorrhagic complications with modest doses of warfarin.
    Kopf GS; Hammond GL; Geha AS; Elefteriades J; Hashim SW
    Circulation; 1987 Sep; 76(3 Pt 2):III132-6. PubMed ID: 3621536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.